A share price of Revelation Biosciences Inc [REVB] is currently trading at $4.12, up 20.12%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The REVB shares have gain 30.79% over the last week, with a monthly amount drifted -68.28%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 13, February 2024, Revelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024). In a post published today on Yahoo Finance, – Oral presentation in addition to poster presentation announced January 30, 2024 –.
From an analyst’s perspective:
Revelation Biosciences Inc experienced fluctuations in its stock price throughout the past year between $2.40 and $69.30. Revelation Biosciences Inc [NASDAQ: REVB] shares were valued at $4.12 at the most recent close of the market.
Analyzing the REVB fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at 0.61, Equity is 1.11 and Total Capital is -0.86. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -0.33.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.57 points at the first support level, and at 3.01 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.51, and for the 2nd resistance point, it is at 4.89.
Revelation Biosciences Inc [REVB] reported earnings per share of -$12.6 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$9/share, meaning a difference of -$3.6 and a surprise factor of -40.00%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$7.5 per share as compared to estimates of -$12 per share, a difference of $4.5 representing a surprise of 37.50%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Revelation Biosciences Inc [NASDAQ:REVB] is 2.62. Further, the Quick Ratio stands at 2.62, while the Cash Ratio is 2.59.
Transactions by insiders
Recent insider trading involved TIDMARSH GEORGE F, Director, that happened on Dec 08 when 27771.0 shares were sold. Director, TIDMARSH GEORGE F completed a deal on Oct 16 to sell 10957.0 shares. Meanwhile, Director TIDMARSH GEORGE F sold 1845.0 shares on Oct 16.
